Glenmark looks to face US DOJ's antitrust claims over drugs separate from Teva
MLex Summary: Glenmark has asked a US judge to sever antitrust claims filed against it by the Department of Justice over the drug pravastatin from claims against Teva Pharmaceuticals. “Counts Two...To view the full article, register now.
Already a subscriber? Click here to view full article